Publication | Closed Access

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke

Cell DeathRat ModelCerebral Vascular RegulationStrokeNormalizes NeurogenesisBrain InjuryNeurologyMicrovascular DysfunctionNeuroimmunologyAtherosclerosisIschemic SyndromeVascular BiologyNeuroprotectionCerebral Blood FlowReperfusion InjuryPharmacologyIschemic StrokeDiabetesDiabetes Drug SemaglutideNeuroscienceMedicine